HIGHLIGHTS
- who: Andrea Modrego et al. from the Institut Biotecnologia Biomedicina, Universitat Autònoma Barcelona, Barcelona, Madrid, Spain, Facultad Ciencias Químicas, Universidad Nacional, have published the paper: Human -Galactosidase A Mutants: Priceless Tools to Develop Novel Therapies for Fabry Disease, in the Journal: (JOURNAL)
- what: The current availability of animal models together with the study and characterization of GLA mutants can be used as tools for the purpose.
- future: Studies exploring the development of ADAs in FD patients using ERT and the potential impact of such antibodies on the efficacy of the therapy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.